Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension, March 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 166 articles:
HTML format


 

Single Articles

  1. BATRA J, Mourad M, Collado FK, Takeda K, et al
    Case report of pregnancy complicated by severe pulmonary hypertension from mitral stenosis and placenta accreta spectrum disorder: management of two life-threatening conditions.
    Eur Heart J Case Rep. 2024;8:ytae055.
    PubMed    
    Abstract available

  2. MUELLER-GRAF F, Frenkel P, Merz J, Reuter S, et al
    Respiratory gating improves correlation between pulse wave transit time and pulmonary artery pressure in experimental pulmonary hypertension.
    Physiol Meas. 2024 Feb 29. doi: 10.1088/1361-6579.
    PubMed    
    Abstract available

  3. ISHIZU T, Hayashi Y, Tokushige N, Omura J, et al
    Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan.
    Curr Med Res Opin. 2024 Feb 29:1-13. doi: 10.1080/03007995.2024.2323632.
    PubMed    
    Abstract available

  4. IVARSSON B, Johansson A, Kjellstrom B
    Change in health-related quality of life at early follow-up in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2024;14:e12349.
    PubMed    
    Abstract available

  5. SOLTANI HEKMAT A, Amini F, Javanmardi K
    Effects of alamandine on monocrotaline-induced pulmonary hypertension in rats.
    Iran J Basic Med Sci. 2024;27:500-508.
    PubMed    
    Abstract available

  6. ARANGO-GRANADOS MC, Osorio-Gonzalez LJ, Munoz-Patino V
    Bedside Ultrasound to Guide the Diagnosis and Treatment of Fulminant Right Heart Failure: A Case Report.
    Am J Case Rep. 2024;25:e942694.
    PubMed    
    Abstract available

  7. VAN DE VEERDONK MC, Roosma L, Trip P, Gopalan D, et al
    Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
    Eur Respir Rev. 2024;33:230144.
    PubMed    
    Abstract available

  8. GAO X, Jiang X, Wu Z, Chen N, et al
    Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.
    J Interv Cardiol. 2024;2024:4512655.
    PubMed    
    Abstract available

  9. WANG Y, Zhu Z, Niu L, Liu B, et al
    Geometric remodeling of tricuspid valve in pulmonary hypertension and its correlation with pulmonary hypertension severity: a prospectively case-control study using four-dimensional automatic tricuspid valve quantification technology.
    Quant Imaging Med Surg. 2024;14:1699-1715.
    PubMed    
    Abstract available

  10. IMAI S, Sakao S, Nagata J, Naito A, et al
    Artificial intelligence-based model for predicting pulmonary arterial hypertension on chest x-ray images.
    BMC Pulm Med. 2024;24:101.
    PubMed    
    Abstract available

  11. PAEZ-CARPIO A, Vollmer I, Zarco FX, Matute-Gonzalez M, et al
    Imaging of chronic thromboembolic pulmonary hypertension before, during and after balloon pulmonary angioplasty.
    Diagn Interv Imaging. 2024 Feb 26:S2211-5684(24)00040.
    PubMed    
    Abstract available

  12. LI M, Shang X, Lou H, Wang Z, et al
    Active Anchoring Stimuli-responsive Nano-craft to relieve Pulmonary Vasoconstriction by Targeting Smooth Muscle Cell for Hypoxic Pulmonary Hypertension Treatment.
    Adv Healthc Mater. 2024 Feb 27:e2400113. doi: 10.1002/adhm.202400113.
    PubMed    
    Abstract available

  13. VATRANO M, Manzi G, Picariello C, D'Alto M, et al
    [ANMCO/SIC Consensus statement on pulmonary arterial hypertension].
    G Ital Cardiol (Rome). 2024;25:192-201.
    PubMed    
    Abstract available

  14. DENG W, Guo W, Yang A, Lin D, et al
    A better method to evaluate the reliability of echocardiography for assessment of pulmonary hypertension: comparison of tricuspid regurgitant spectrum quality grading and tricuspid valve regurgitation degree.
    J Thorac Dis. 2024;16:51-64.
    PubMed    
    Abstract available

  15. KIMYON AS, Cetinkaya A, Hallioglu Kilinc O, Aras N, et al
    The evaluation of the SMAD1 rs1016792 polymorphism and gene expression on pulmonary hypertension due to congenital heart disease in children: a preliminary study.
    Nucleosides Nucleotides Nucleic Acids. 2024.
    PubMed    
    Abstract available

  16. NAKANO T, Wada S, Nishisako R, Sakurai Y, et al
    Massive hemoptysis from a bronchial-pulmonary arterial fistula.
    Pediatr Int. 2024;66:e15741.
    PubMed    


  17. ESTRADA RA, Auger WR, Sahay S
    Chronic Thromboembolic Pulmonary Hypertension.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265.
    PubMed    


  18. HRYZHAK I, Pryshliak O, Kobryn T, Fedorov S, et al
    Clinical and echocardiographic findings in patients with COVID-19 across different severity levels.
    J Med Life. 2023;16:1692-1700.
    PubMed    
    Abstract available

  19. JI XY, Lei CJ, Kong S, Li HF, et al
    Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension.
    Drug Des Devel Ther. 2024;18:475-491.
    PubMed    
    Abstract available

  20. YANG X, Sun J, Yang H, Guo T, et al
    [Diagnosis of pulmonary hypertension associated with congenital heart disease based on statistical features of the second heart sound].
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024;41:41-50.
    PubMed    
    Abstract available

  21. SANIVARAPU RR, Arjun S, Otero J, Munshi R, et al
    In-hospital outcomes of pulmonary hypertension in HIV patients: A population based cohort study.
    Int J Cardiol. 2024 Feb 23:131900. doi: 10.1016/j.ijcard.2024.131900.
    PubMed    
    Abstract available

  22. KENNEWEG F, Hobohm L, Bang C, Gupta SK, et al
    Circulating miR-let7a levels predict future diagnosis of chronic thromboembolic pulmonary hypertension.
    Sci Rep. 2024;14:4514.
    PubMed    
    Abstract available

  23. KAYALI SM, Dietz BE 2nd, Siddiq BS, Ghaly M, et al
    Chronic thromboembolic pulmonary hypertension and balloon pulmonary angioplasty - Where are we in 2024?
    Curr Probl Cardiol. 2024;49:102481.
    PubMed    
    Abstract available

  24. FOROSHANI S, Airo M, Levine A, Frishman WH, et al
    COVID-19 and Pulmonary Hypertension: An Interesting Dynamic.
    Cardiol Rev. 2024 Feb 24. doi: 10.1097/CRD.0000000000000679.
    PubMed    
    Abstract available

  25. MERELES D, Rudolph J, Greiner S, Aurich M, et al
    Acute changes in cardiac dimensions, function, and longitudinal mechanics in healthy individuals with and without high-altitude induced pulmonary hypertension at 4559 m.
    Echocardiography. 2024;41:e15786.
    PubMed    
    Abstract available

  26. EREMINIENE E, Stuoka M, Ordiene R, Plisiene J, et al
    Acquired Cardiovascular Diseases in Patients with Pulmonary Hypertension Due to Congenital Heart Disease: A Case Report.
    Medicina (Kaunas). 2024;60:266.
    PubMed    
    Abstract available

  27. GONCHAROVA N, Lapshin K, Berezina A, Simakova M, et al
    Elderly Patients with Idiopathic Pulmonary Hypertension: Clinical Characteristics, Survival, and Risk Stratification in a Single-Center Prospective Registry.
    Life (Basel). 2024;14:259.
    PubMed    
    Abstract available

  28. WEI ZX, Cai XX, Fei YD, Wang Q, et al
    Ntsr1 contributes to pulmonary hypertension by enhancing endoplasmic reticulum stress via JAK2-STAT3-Thbs1 signaling.
    Transl Res. 2024 Feb 21:S1931-5244(24)00031-8. doi: 10.1016/j.trsl.2024.
    PubMed    
    Abstract available

  29. WANG Y, Rong C, Liu J, Liu X, et al
    Pulmonary arterial sarcoma: A case report.
    Medicine (Baltimore). 2024;103:e37194.
    PubMed    
    Abstract available

  30. ASAL AEA, Oshaiba ZF, Mansour ENA, Abd Elaziz OH, et al
    Serum pentraxin 3 levels in term neonates with persistent pulmonary hypertension.
    J Neonatal Perinatal Med. 2024 Feb 21. doi: 10.3233/NPM-230211.
    PubMed    
    Abstract available

  31. SEKI N, Tsujimoto H, Tanemura S, Ishigaki S, et al
    Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
    Cytokine. 2024;176:156534.
    PubMed    
    Abstract available

  32. TANG L, Zhou X, Guo A, Han L, et al
    Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling.
    Cardiovasc Toxicol. 2024;24:158-170.
    PubMed    
    Abstract available

  33. PICCINELLI E, Frazzetto F, Pilati M, Butera G, et al
    Stent Implantation Across the Atrial Flow Regulator Device.
    Pediatr Cardiol. 2024;45:695-698.
    PubMed    
    Abstract available

  34. LIPCZYNSKA M, Derejska M, Swierczynski R, Kusmierczyk-Droszcz B, et al
    Noncardiac surgery in Eisenmenger syndrome.
    Pol Arch Intern Med. 2024;134:16652.
    PubMed    


  35. CONNES P
    Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness.
    Clin Hemorheol Microcirc. 2024;86.
    PubMed    
    Abstract available

  36. JIA Q, Ouyang Y, Yang Y, Yao S, et al
    Osteopontin: A Novel Therapeutic Target for Respiratory Diseases.
    Lung. 2024;202:25-39.
    PubMed    
    Abstract available

  37. LIN K, Sarnari R, Gordon DZ, Markl M, et al
    Cine MRI-derived radiomics features indicate hemodynamic changes in the pulmonary artery.
    Int J Cardiovasc Imaging. 2024;40:287-294.
    PubMed    
    Abstract available

  38. FULOP P, Valocik G, Barbierik Vachalcova M, Zenuch P, et al
    Aortic stenosis and right ventricular dysfunction.
    Int J Cardiovasc Imaging. 2024;40:299-305.
    PubMed    
    Abstract available

  39. CAIN MT, Schafer M, Park S, Barker AJ, et al
    Characterization of pulmonary arterial stiffness using cardiac MRI.
    Int J Cardiovasc Imaging. 2024;40:425-439.
    PubMed    
    Abstract available

  40. ANASTASIOU V, Papazoglou AS, Moysidis DV, Daios S, et al
    The prognostic impact of right ventricular-pulmonary arterial coupling in heart failure: a systematic review and meta-analysis.
    Heart Fail Rev. 2024;29:13-26.
    PubMed    
    Abstract available

  41. SONG J, Chen Y, Chen Y, Wang S, et al
    Ferrostatin-1 Blunts Right Ventricular Hypertrophy and Dysfunction in Pulmonary Arterial Hypertension by Suppressing the HMOX1/GSH Signaling.
    J Cardiovasc Transl Res. 2024;17:183-196.
    PubMed    
    Abstract available

  42. CHAO C, Wang M, Mei K, Ma C, et al
    An inverse causal relationship between serum 25-hydroxyvitamin D levels and pulmonary hypertension: A two-sample Mendelian randomization study.
    Pulm Circ. 2024;14:e12350.
    PubMed    
    Abstract available

  43. TERUI Y, Ohura S, Nozaki T, Yagi T, et al
    Pulmonary hypertension in an adult patient with congenital central hypoventilation syndrome: a case report.
    Eur Heart J Case Rep. 2024;8:ytae109.
    PubMed    
    Abstract available

  44. LI X, Zhang Y, Zhang S, Zhao Q, et al
    Tumor biomarkers in evaluating the severity and prognosis of idiopathic pulmonary arterial hypertension: A comprehensive analysis.
    Clin Transl Sci. 2024;17:e13751.
    PubMed    
    Abstract available

  45. KAVGACI A, Kula S, Berber Marasli E, Zinnuroglu M, et al
    Evaluation of handgrip strength in children with pulmonary hypertension.
    Cardiol Young. 2024 Mar 7:1-5. doi: 10.1017/S1047951124000398.
    PubMed    
    Abstract available

  46. WU XF, Sun TT, Lin JL, Guo WL, et al
    [Pulmonary artery stenting in chronic thromboembolic pulmonary hypertension: a report of 2 cases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:228-232.
    PubMed    
    Abstract available

  47. MESSIKA J, Eloy P, Boulate D, Charvet A, et al
    Protocol for venoarterial ExtraCorporeal Membrane Oxygenation to reduce morbidity and mortality following bilateral lung TransPlantation: the ECMOToP randomised controlled trial.
    BMJ Open. 2024;14:e077770.
    PubMed    
    Abstract available

  48. WANG Y, Guo D, Gong J, Wang J, et al
    Efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with pulmonary comorbidity.
    Int J Cardiol Heart Vasc. 2024;51:101363.
    PubMed    
    Abstract available

  49. PILIERO N, Salvat M, Finas M, Curioz F, et al
    Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2024;10:00085-2024.
    PubMed    
    Abstract available

  50. VURAN G, Yilmazer MM, Gerceker E, Zihni C, et al
    Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension.
    Cardiol Young. 2024 Mar 6:1-5. doi: 10.1017/S1047951124000362.
    PubMed    
    Abstract available

  51. LIU H, Zhang YW, Zhang QQ, Wang YX, et al
    [Effects of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes on pulmonary vascular remodeling in hypoxic pulmonary hypertension].
    Sheng Li Xue Bao. 2024;76:33-44.
    PubMed    
    Abstract available

  52. MADDALONI C, Ronci S, De Rose DU, Bersani I, et al
    Neonatal persistent pulmonary hypertension related to a novel TBX4 mutation: case report and review of the literature.
    Ital J Pediatr. 2024;50:41.
    PubMed    
    Abstract available

  53. ITTERMANN T, Kaczmarek S, Obst A, Konemann R, et al
    Metabolic cost of unloading pedalling in different groups of patients with pulmonary hypertension and volunteers.
    Sci Rep. 2024;14:5394.
    PubMed    
    Abstract available

  54. ANH NTH, Minh Dien T, Thi Ha L, Thao Nguyen P, et al
    Factors in the Neonatal Period Associated With Pulmonary Hypertension at 28 Days of Life in Broncho-Pulmonary Dysplasia.
    Glob Pediatr Health. 2024;11:2333794X241234571.
    PubMed    
    Abstract available

  55. TENZING D, Suolang P, Gesang D, Suolang D, et al
    Effect of furosemide in the treatment of high-altitude pulmonary edema.
    BMC Pulm Med. 2024;24:109.
    PubMed    
    Abstract available

  56. MUNTEANU A, Kundnani NR, Caraba A
    Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
    Eur Rev Med Pharmacol Sci. 2024;28:1314-1326.
    PubMed    
    Abstract available

  57. CROWLEY AV, Banfield M, Gupta A, Raj R, et al
    Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
    Cureus. 2024;16:e53336.
    PubMed    
    Abstract available

  58. PENATE GP, Parra NO, Morera JAD, Menaca AM, et al
    Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare digital platform in pulmonary arterial hypertension: a pilot study.
    Front Public Health. 2024;12:1335072.
    PubMed    
    Abstract available

  59. ZAHID S, Anjali Garg J, Altibi A, Golwala H, et al
    Mitral Transcatheter Edge-to-Edge Repair: Advancing Treatment Options for Degenerative Mitral Regurgitation.
    Interv Cardiol Clin. 2024;13:155-165.
    PubMed    
    Abstract available

  60. RANGWALA BS, Sohail Rangwala H
    Comment on: Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review.
    Curr Probl Cardiol. 2024 Feb 29:102492. doi: 10.1016/j.cpcardiol.2024.102492.
    PubMed    
    Abstract available

  61. MORA-CUESTA VM, Martinez-Menaca A, Iturbe-Fernandez D, Tello-Mena S, et al
    Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients.
    Heart Lung Circ. 2024 Feb 29:S1443-9506(24)00037.
    PubMed    
    Abstract available

  62. LI J, Xiong J, Liu P, Peng Y, et al
    Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Adv Rheumatol. 2024;64:15.
    PubMed    
    Abstract available

  63. WHITE RJ, Lachant DJ, Benza RL
    Risk scores as a surrogate in pulmonary arterial hypertension: a different lens.
    Lancet Respir Med. 2024;12:e9-e10.
    PubMed    


  64. HARHAY MO, Blette BS, Kawut SM
    Risk scores as a surrogate in pulmonary arterial hypertension: a different lens - Authors' reply.
    Lancet Respir Med. 2024;12:e11.
    PubMed    


  65. HODNICK R, Cohen ML, Loehner JB, Mazzanti J, et al
    Continuous Positive Airway Pressure in the Treatment of Pediatric High Altitude Pulmonary Edema: A Case Study.
    Wilderness Environ Med. 2024;35:78-81.
    PubMed    
    Abstract available

  66. QIAN YL, He JG
    [Current status and progress of research on pediatric pulmonary arterial hypertension].
    Zhonghua Er Ke Za Zhi. 2024;62:278-281.
    PubMed    


  67. HIRANO Y, Amano M, Obokata M, Izumo M, et al
    Practice guidance for stress echocardiography.
    J Echocardiogr. 2024;22:1-15.
    PubMed    
    Abstract available

  68. MATHUR M, Malinowski M, Jazwiec T, Timek TA, et al
    Leaflet remodeling reduces tricuspid valve function in a computational model.
    J Mech Behav Biomed Mater. 2024;152:106453.
    PubMed    
    Abstract available

  69. SANDEEP B, Cheng H, Yan Y, Huang X, et al
    Right ventricle-pulmonary artery coupling in pulmonary artery hypertension its measurement and pharmacotherapy.
    Curr Probl Cardiol. 2024;49:102425.
    PubMed    
    Abstract available

  70. SHORT K, McBride M, Anderson S, Miller R, et al
    Survival of Infants With Severe Congenital Kidney Disease After ECMO and Kidney Support Therapy.
    Pediatrics. 2024 Feb 2:e2023062717. doi: 10.1542/peds.2023-062717.
    PubMed    
    Abstract available

  71. CUETO-ROBLEDO G, Tovar-Benitez D, Alfaro-Cruz A, Gonzalez-Hermosillo LM, et al
    Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.
    Curr Probl Cardiol. 2024;49:102404.
    PubMed    
    Abstract available

  72. HAIDER MA, Pearce KJ, Chesler NC, Hill NA, et al
    Application and reduction of a nonlinear hyperelastic wall model capturing ex vivo relationships between fluid pressure, area, and wall thickness in normal and hypertensive murine left pulmonary arteries.
    Int J Numer Method Biomed Eng. 2024;40:e3798.
    PubMed    
    Abstract available

  73. LI XM, Zhu XJ, Jing ZC
    Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
    Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
    PubMed    


  74. LI M, Pan W, Tian D, Chen D, et al
    Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.
    Curr Vasc Pharmacol. 2024;22:67-77.
    PubMed    
    Abstract available

  75. PEREZ-VIZCAINO F, Barbera JA, Rodriguez Chiaradia DA
    Vitamin D and Pulmonary Arterial Hypertension.
    Arch Bronconeumol. 2024;60:131-132.
    PubMed    


  76. HEO J, Kang H
    Platelet-derived growth factor-stimulated pulmonary artery smooth muscle cells regulate pulmonary artery endothelial cell dysfunction through extracellular vesicle miR-409-5p.
    Biol Chem. 2023;405:203-215.
    PubMed    
    Abstract available

  77. ALY S, Qattea I, Othman H, Nguyen HH, et al
    Outcomes of atrioventricular septal defects with and without down syndrome: analysis of the national inpatient database.
    Cardiol Young. 2024;34:614-623.
    PubMed    
    Abstract available

  78. MATSUMOTO K, Miyawaki Y, Katsuyama T, Nakadoi T, et al
    Immunosuppressive Treatment for an anti-U(1) Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension.
    Intern Med. 2024;63:671-676.
    PubMed    
    Abstract available

  79. PAVSIC N, Kacar P, Dolenc J, Prokselj K, et al
    One-minute sit-to-stand test in patients with pulmonary arterial hypertension associated with congenital heart disease: A single-center prospective study.
    Hellenic J Cardiol. 2024;75:41-47.
    PubMed    
    Abstract available

  80. PANAGIOTIDOU E, Betaoutou A, Fouka E, Papakosta D, et al
    Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics.
    Pulmonology. 2024;30:104-112.
    PubMed    
    Abstract available

  81. UNALDI E, Firlatan B, Duzgun SA, Koca SS, et al
    Case report: Pulmonary endarterectomy in Takayasu arteritis patient with group IV pulmonary hypertension: A rare clinical scenario.
    Int J Rheum Dis. 2024;27:e15119.
    PubMed    


  82. MONDEN Y, Une D, Mitsumune S, Shimokawahara H, et al
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with bronchial obstruction by a carcinoid tumor.
    Pulm Circ. 2024;14:e12354.
    PubMed    
    Abstract available

  83. WILSON BK, Sadowski CK, Baeten RG
    A clinician's guide to pulmonary hypertension.
    JAAPA. 2024 Mar 14. doi: 10.1097/01.JAA.0001007360.09090.
    PubMed    
    Abstract available

  84. CHANG AJ, Goh CH
    Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation.
    Tex Heart Inst J. 2024;51:e238209.
    PubMed    
    Abstract available

  85. GERGES C, Vollmers K, Skoro-Sajer N, Dannenberg V, et al
    Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension.
    Eur J Heart Fail. 2024 Mar 13. doi: 10.1002/ejhf.3187.
    PubMed    
    Abstract available

  86. BONGIOVANNI G, Tonutti A, Stainer A, Nigro M, et al
    Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review.
    BMJ Open Respir Res. 2024;11:e002161.
    PubMed    
    Abstract available

  87. KITAGHENDA FK, Hidig SM
    Improvement in Pulmonary Hypertension Following Metabolic and Bariatric Surgery: a Brief Review and Meta-analysis.
    Obes Surg. 2024 Mar 13. doi: 10.1007/s11695-024-07162.
    PubMed    
    Abstract available

  88. BHAGWAT AP, Sharath HV, Seth NH, Puri SN, et al
    Persistent Pulmonary Hypertension of Newborns Secondary to Labile Hypoxemia Associated With Cyanosis: A Case Series.
    Cureus. 2024;16:e54016.
    PubMed    
    Abstract available

  89. DIALLO TH, Nana Yeboah F, Djafarou Boubacar R, Faraj R, et al
    Severe pulmonary hypertension associated with hypothyroidism and mixed aortic valve disease: A case report.
    SAGE Open Med Case Rep. 2024;12:2050313X241237405.
    PubMed    
    Abstract available

  90. HU Z, Fan S
    Progress in the application of echocardiography in neonatal pulmonary hypertension.
    J Matern Fetal Neonatal Med. 2024;37:2320673.
    PubMed    
    Abstract available

  91. MUNKS J, Yogeswaran A, Antoine TK, Blumrich LA, et al
    A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding.
    Int J Mol Sci. 2024;25:2827.
    PubMed    
    Abstract available

  92. WANG MT, Weng KP, Chang SK, Huang WC, et al
    Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
    Int J Mol Sci. 2024;25:2734.
    PubMed    
    Abstract available

  93. RESHMA S J, George S, P SK 5th
    Pulmonary hypertension in newly diagnosed obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome patients attending a tertiary care centre-a cross-sectional analysis.
    Ir J Med Sci. 2024 Mar 12. doi: 10.1007/s11845-024-03657.
    PubMed    
    Abstract available

  94. MORRISROE K, Hansen D, Stevens W, Ross L, et al
    Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis.
    Rheumatology (Oxford). 2024 Mar 12:keae166. doi: 10.1093.
    PubMed    
    Abstract available

  95. DE JAGER J, Brouwer F, Reijman J, van der Palen RLF, et al
    Occurrence of hyperoxia during iNO treatment for persistent pulmonary hypertension of the newborn: a cohort study.
    Eur J Pediatr. 2024 Mar 12. doi: 10.1007/s00431-024-05506.
    PubMed    
    Abstract available

  96. PEREZ-PENATE GM, Julia-Serda G, Galvan-Fernandez H, Aleman-Segura D, et al
    Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension.
    Pulm Circ. 2024;14:e12344.
    PubMed    
    Abstract available

  97. ALOTAIBI M, Yang JZ, Papamatheakis DG, McGuire WC, et al
    Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease.
    Respir Res. 2024;25:121.
    PubMed    
    Abstract available

  98. SUNG C, Han S, Yoon S, Han SA, et al
    Diagnostic Performance of Perfusion-Only SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension in Comparison With Ventilation-Perfusion Planar, SPECT, and SPECT/CT Imaging.
    Clin Nucl Med. 2024 Mar 11. doi: 10.1097/RLU.0000000000005142.
    PubMed    
    Abstract available

  99. HU BZ, Jiang C, Ding YJ, Qin W, et al
    The clinical and hemodynamic characteristics of pulmonary hypertension in patients with OSA-COPD overlap syndrome.
    Am J Med Sci. 2024 Mar 9:S0002-9629(24)01120-0. doi: 10.1016/j.amjms.2024.
    PubMed    
    Abstract available

  100. JAMOUSSI A, Ben Mrad N, Rachdi E, Jarraya F, et al
    Hemodynamic profile of pulmonary arterial hypertension in a Tunisian center.
    Tunis Med. 2023;101:751-755.
    PubMed    
    Abstract available

  101. ADACHI T, Adachi S, Nakano Y, Yasuda K, et al
    Detrimental Impact of Comorbid Mental Disorders in Chronic Thromboembolic Pulmonary Hypertension?- A Retrospective Observational Study.
    Circ Rep. 2024;6:80-85.
    PubMed    
    Abstract available

  102. LONG C, Fan W, Liu Y, Hong K, et al
    Stress hyperglycemia is associated with poor outcome in critically ill patients with pulmonary hypertension.
    Front Endocrinol (Lausanne). 2024;15:1302537.
    PubMed    
    Abstract available

  103. KHEZERLOUY-AGHDAM N, Toufan Tabrizi M, Seyed Toutounchi K, Jabbaripour Sarmadian A, et al
    Challenging in pulmonary thromboembolism diagnosis in patients with disproportionate pulmonary hypertension and severe mitral stenosis: Report of two cases.
    Clin Case Rep. 2024;12:e8597.
    PubMed    
    Abstract available

  104. LIU B, Yi D, Xia X, Ramirez K, et al
    General Capillary Endothelial Cells Undergo Reprogramming into Arterial Endothelial Cells in Pulmonary Hypertension through HIF-2alpha/Notch4 Pathway.
    bioRxiv [Preprint]. 2024 Mar 10:2024.02.13.580227.
    PubMed    
    Abstract available

  105. KUSNER J, Krasuski RA
    Pulmonary Hypertension in Adult Congenital Heart Disease-Related Heart Failure.
    Heart Fail Clin. 2024;20:209-221.
    PubMed    
    Abstract available

  106. ZHOU S, Zhang Q, Yang H, Zhu Y, et al
    Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH.
    Life Sci. 2024;342:122538.
    PubMed    
    Abstract available

  107. ZHANG H, Wang X, Liu J, Zhang Y, et al
    Role of neutrophil myeloperoxidase in the development and progression of high-altitude pulmonary edema.
    Biochem Biophys Res Commun. 2024;703:149681.
    PubMed    
    Abstract available

  108. MANZI G, Mariani MV, Filomena D, Recchioni T, et al
    Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis.
    Vascul Pharmacol. 2024;154:107280.
    PubMed    
    Abstract available

  109. LIU C, Lv X, Kong X, Meng L, et al
    Ultrasound-mediated HGF Gene Microbubbles Mitigate Hyperkinetic Pulmonary Arterial Hypertension in Rabbits.
    Heart Lung Circ. 2024;33:251-259.
    PubMed    
    Abstract available

  110. CHI PL, Cheng CC, Wang MT, Liao JB, et al
    Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1alpha and Runx2.
    Cardiovasc Res. 2024;120:203-214.
    PubMed    
    Abstract available

  111. BRADY S, Krishnan U, Saqi A, Vargas D, et al
    Twins with alveolar capillary dysplasia with misalignment of pulmonary veins: Strategies for diagnosis and management.
    J Neonatal Perinatal Med. 2024;17:147-152.
    PubMed    
    Abstract available

  112. CORRADO A, Mansueto N, Correale M, Rella V, et al
    Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers.
    Vascul Pharmacol. 2024;154:107252.
    PubMed    
    Abstract available

  113. DIGNAM JP, Sharma S, Stasinopoulos I, MacLean MR, et al
    Pulmonary arterial hypertension: Sex matters.
    Br J Pharmacol. 2024;181:938-966.
    PubMed    
    Abstract available

  114. MAMAZHAKYPOV A, Veith C, Schermuly RT, Sydykov A, et al
    Surgical protocol for pulmonary artery banding in mice to generate a model of pressure-overload-induced right ventricular failure.
    STAR Protoc. 2023;4:102660.
    PubMed    
    Abstract available

  115. POUDEL S, Gautam S, Adhikari P, Zafren K, et al
    Physiological Effects of Sildenafil Versus Placebo at High Altitude: A Systematic Review.
    High Alt Med Biol. 2024;25:16-25.
    PubMed    
    Abstract available

  116. CHEN CY, Mei-Tzu W, Sung SH, Wu YJ, et al
    Exercise capacity-hemodynamics mismatch in elderly patients with pulmonary hypertension: A nationwide multicenter study from Taiwan Society of Cardiology Pulmonary Hypertension Registry (TAIPANS).
    Heliyon. 2024;10:e27537.
    PubMed    
    Abstract available

  117. ROMMEL KP, Hobohm L, Rothman AMK, Lurz P, et al
    Radiation to Illuminate the Path of Neuromodulation for Pulmonary Hypertension.
    JACC Basic Transl Sci. 2024;9:257-259.
    PubMed    


  118. HORN-OUDSHOORN EJJ, Vermeulen MJ, Knol R, Bout-Rebel R, et al
    Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan.
    Trials. 2024;25:198.
    PubMed    
    Abstract available

  119. BENZA RL, Grunig E, Sandner P, Stasch JP, et al
    The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
    Eur Respir Rev. 2024;33:230183.
    PubMed    
    Abstract available

  120. KIM MS, Jeon K, Kim EK, Park TK, et al
    Usefulness of cardiopulmonary exercise test combined with exercise stress echocardiography in mild chronic thromboembolic pulmonary disease.
    Echocardiography. 2024;41:e15795.
    PubMed    
    Abstract available

  121. VALLADALES-RESTREPO LF, Gaviria-Mendoza A, Machado-Duque ME, Vallejos-Narvaez A, et al
    Prescription patterns of ambrisentan in some cities of Colombia.
    Clin Respir J. 2024;18:e13736.
    PubMed    
    Abstract available

  122. HEMILA H, de Man AME
    Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports.
    BMC Pulm Med. 2024;24:140.
    PubMed    
    Abstract available

  123. SMUKOWSKA-GORYNIA A, Iwanczyk S, Rzymski P, Wozniak P, et al
    Situation of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic (2020-2022): clinical outcomes, prognostic factors, and response to vaccination.
    Pol Arch Intern Med. 2024 Mar 19:16706. doi: 10.20452/pamw.16706.
    PubMed    


  124. VARIAN F, Dick J, Battersby C, Roman S, et al
    Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.
    Pulm Circ. 2024;14:e12337.
    PubMed    
    Abstract available

  125. BUDHRAM B, Weatherald J, Humbert M
    Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.
    Semin Respir Crit Care Med. 2024 Mar 18. doi: 10.1055/s-0044-1782217.
    PubMed    
    Abstract available

  126. HU X, Sun Y, Wang S, Zhao H, et al
    CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.
    J Am Heart Assoc. 2024;13:e031867.
    PubMed    
    Abstract available

  127. DUARTE VE
    Women and the Heart: Gender-Related Differences in Cardiovascular Care.
    Methodist Debakey Cardiovasc J. 2024;20:1-3.
    PubMed    


  128. PARK E, Safdar Z
    Pulmonary Hypertension in Women.
    Methodist Debakey Cardiovasc J. 2024;20:70-80.
    PubMed    
    Abstract available

  129. LIU J, Fang G, Lan C, Qiu C, et al
    Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-kappaB Signaling Pathway to Attenuate Vascular Remodeling.
    Drug Des Devel Ther. 2024;18:767-780.
    PubMed    
    Abstract available

  130. XIA W, Qian Y, Lin Y, Quan R, et al
    Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry.
    Respirology. 2024 Mar 17. doi: 10.1111/resp.14700.
    PubMed    
    Abstract available

  131. PROVENCHER S, Arsenault BJ, Bonnet S
    Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries.
    J Am Heart Assoc. 2024;13:e033446.
    PubMed    


  132. ALHATHLI E, Julian T, Girach ZUA, Thompson AAR, et al
    Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2024;13:e032256.
    PubMed    
    Abstract available

  133. GUAN D, Tian L, Li W, Gao H, et al
    Using LDDMM and a kinematic cardiac growth model to quantify growth and remodelling in rat hearts under PAH.
    Comput Biol Med. 2024;171:108218.
    PubMed    
    Abstract available

  134. TAN JS, Yang Y, Wang J, Wang Y, et al
    Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study.
    Biosci Trends. 2024;18:94-104.
    PubMed    
    Abstract available

  135. ZHANG C, Xi Y, Zhang Y, He P, et al
    Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study.
    Heart Lung. 2024;64:189-197.
    PubMed    
    Abstract available

  136. GAWLITZA J, Endres S, Fries P, Graf M, et al
    Machine learning assisted feature identification and prediction of hemodynamic endpoints using computed tomography in patients with CTEPH.
    Int J Cardiovasc Imaging. 2024;40:569-577.
    PubMed    
    Abstract available

  137. SCHIFFRIN EL, Pollock DM
    Endothelin System in Hypertension and Chronic Kidney Disease.
    Hypertension. 2023 Dec 7. doi: 10.1161/HYPERTENSIONAHA.123.21716.
    PubMed    
    Abstract available

  138. ZHOU R, Zhao Z, Liu J, Liu M, et al
    Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis.
    Heart Lung. 2024;64:36-45.
    PubMed    
    Abstract available

  139. DWIVEDI K, Sharkey M, Alabed S, Langlotz CP, et al
    External validation, radiological evaluation, and development of deep learning automatic lung segmentation in contrast-enhanced chest CT.
    Eur Radiol. 2024;34:2727-2737.
    PubMed    
    Abstract available

  140. MEIFANG W, Ying W, Wen C, Kaizu X, et al
    Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
    Heart Fail Rev. 2024;29:305-320.
    PubMed    
    Abstract available

  141. KUDRYASHOVA TV, Jiang L, Goncharova EA
    What Is All of the Hype About? Hypusine Signaling as a Driver of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2024 Feb 27. doi: 10.1164/rccm.202401-0195.
    PubMed    


  142. LILEY J, Newnham M, Bleda M, Bunclark K, et al
    Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.
    Am J Respir Crit Care Med. 2024 Mar 12. doi: 10.1164/rccm.202307-1236.
    PubMed    
    Abstract available

  143. HARDER E, Abtin F, Nardelli P, Brownstein A, et al
    Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.
    Am J Respir Crit Care Med. 2024 Mar 19. doi: 10.1164/rccm.202312-2343.
    PubMed    


  144. JAIN A, Epelbaum O
    Synchronous Pulmonary Arterial and Pulmonary Venous Thrombosis in Pancreatic Cancer.
    Am J Respir Crit Care Med. 2024;209:751-752.
    PubMed    


  145. O'MEARA K, Stone G, Buch E, Brownstein A, et al
    Atrial Arrhythmias in Patients with Pulmonary Hypertension.
    Chest. 2024 Mar 5:S0012-3692(24)00291-5. doi: 10.1016/j.chest.2024.
    PubMed    
    Abstract available

  146. PROVENCHER S, Mai V, Bonnet S
    Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
    Chest. 2024;165:682-691.
    PubMed    
    Abstract available

  147. OROZCO-LEVI M, de Jesus Perez V
    Precision Solutions: A Strategy to Improve Medical Care for Patients With Pulmonary Hypertension in Latin America.
    Chest. 2024;165:669-672.
    PubMed    


  148. SAHAY S
    Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No.
    Chest. 2024;165:494-496.
    PubMed    


  149. WEATHERALD J, Sitbon O
    POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
    Chest. 2024;165:492-494.
    PubMed    


  150. YOGESWARAN A, Gall H, Funderich M, Wilkins MR, et al
    Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis.
    Chest. 2024 Mar 18:S0012-3692(24)00309-X. doi: 10.1016/j.chest.2024.
    PubMed    
    Abstract available

  151. COSTE B, Delmas P
    PIEZO Ion Channels in Cardiovascular Functions and Diseases.
    Circ Res. 2024;134:572-591.
    PubMed    
    Abstract available

  152. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    PubMed    
    Abstract available

  153. HU X, Yuan P, Chen J, Wang S, et al
    Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.
    Clin Cardiol. 2024;47:e24245.
    PubMed    
    Abstract available

  154. MULLER J, Titz A, Schneider SR, Bauer M, et al
    The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled cross-over trial.
    Eur Respir J. 2024 Feb 29:2301001. doi: 10.1183/13993003.01001-2023.
    PubMed    
    Abstract available

  155. NAEIJE R
    High altitude travelling with pulmonary arterial hypertension.
    Eur Respir J. 2024;63:2400111.
    PubMed    


  156. HOWARD LS, Price LC
    Systematic pulmonary embolism follow-up: why we should all do it!
    Eur Respir J. 2024;63:2400253.
    PubMed    


  157. LOWERY MM, Hill NS, Wang L, Mehra R, et al
    Reply: Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
    J Am Coll Cardiol. 2024;83:e109.
    PubMed    


  158. HUANG Z, Duan A, Luo Q, Liu Z, et al
    Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
    J Am Coll Cardiol. 2024;83:e107.
    PubMed    


  159. JHA AK, Rajkumar S, Parida S
    Pulmonary Vascular Resistance-Pulmonary Artery Compliance Relationship and Time Constant in Pulmonary Hypertension Due to Valvular Heart Disease.
    J Cardiothorac Vasc Anesth. 2024 Feb 1:S1053-0770(24)00091.
    PubMed    


  160. BUNCLARK K, Toshner M
    Anthropometrics are important to consider in purported sex differences in CTEPH outcomes.
    J Heart Lung Transplant. 2024;43:688.
    PubMed    


  161. MORONTA SC, Bischoff AR, Ryckman KK, Dagle JM, et al
    Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
    J Perinatol. 2024 Jan 31. doi: 10.1038/s41372-024-01883.
    PubMed    
    Abstract available

  162. CERVERA SB, Saeed S, Luu TM, Gorgos A, et al
    Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.
    J Perinatol. 2024 Jan 26. doi: 10.1038/s41372-024-01877.
    PubMed    
    Abstract available

  163. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
    Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
    PubMed    
    Abstract available

  164. BOUCHET C, Guibert C, Freund-Michel V
    [Nerve growth factor (NGF) in pulmonary hypertension (PH)].
    Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00137-2. doi: 10.1016/j.rmr.2024.
    PubMed    
    Abstract available

  165. NATHAN SD, Johri S, Joly JM, King CS, et al
    Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.
    Thorax. 2024;79:301-306.
    PubMed    
    Abstract available

  166. ZHAN S, Wang L, Wang W, Li R, et al
    Analysis of genes characterizing chronic thrombosis and associated pathways in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2024;19:e0299912.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;